Hospital Regional Universitario de Málaga - Hospital General

Málaga 29011

1 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer Metastatic, Leukemia, Patients With Non-Small Cell Lung Cancer, Prader-Willi Syndrome, Systemic Lupus Erythematosus

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus — Completed
• Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling
• Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome — Completed
• Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer — Completed